We are thrilled to be named “European Cross-border Patent & Regulatory Team of the Year” by Managing IP at their 2024 EMEA Awards.
This is in recognition for our work steering the course in Biogen’s ongoing multi-jurisdictional patent dispute. Our role involves coordinating tens of proceedings in more than 20 European jurisdictions in relation to Tecfidera®, a key treatment for multiple sclerosis.
Sebastian Moore, Head of our UK Intellectual Property practice and lead partner, remarks: “The HSF team has, in close conjunction with Biogen and its partners in Europe, worked hard and to great effect on this matter. It is satisfying to have this recognised”.
From left to right: Natasha Daniell; Julie Chiu; Priyanka Madan; John Lao; Roshni Desai; Charlie Madill; Laura Orlando; Giulia Maienza; Sebastian Moore; Emily Bottle.
